210 related articles for article (PubMed ID: 15060164)
1. Identification of tamoxifen-induced coregulator interaction surfaces within the ligand-binding domain of estrogen receptors.
Heldring N; Nilsson M; Buehrer B; Treuter E; Gustafsson JA
Mol Cell Biol; 2004 Apr; 24(8):3445-59. PubMed ID: 15060164
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanisms of estrogen action: selective ligands and receptor pharmacology.
Katzenellenbogen BS; Choi I; Delage-Mourroux R; Ediger TR; Martini PG; Montano M; Sun J; Weis K; Katzenellenbogen JA
J Steroid Biochem Mol Biol; 2000 Nov; 74(5):279-85. PubMed ID: 11162936
[TBL] [Abstract][Full Text] [Related]
3. The tamoxifen-responsive estrogen receptor alpha mutant D351Y shows reduced tamoxifen-dependent interaction with corepressor complexes.
Yamamoto Y; Wada O; Suzawa M; Yogiashi Y; Yano T; Kato S; Yanagisawa J
J Biol Chem; 2001 Nov; 276(46):42684-91. PubMed ID: 11553641
[TBL] [Abstract][Full Text] [Related]
4. Analysis of ligand-dependent recruitment of coactivator peptides to estrogen receptor using fluorescence polarization.
Ozers MS; Ervin KM; Steffen CL; Fronczak JA; Lebakken CS; Carnahan KA; Lowery RG; Burke TJ
Mol Endocrinol; 2005 Jan; 19(1):25-34. PubMed ID: 15375189
[TBL] [Abstract][Full Text] [Related]
5. Temporally distinct and ligand-specific recruitment of nuclear receptor-interacting peptides and cofactors to subnuclear domains containing the estrogen receptor.
Schaufele F; Chang CY; Liu W; Baxter JD; Nordeen SK; Wan Y; Day RN; McDonnell DP
Mol Endocrinol; 2000 Dec; 14(12):2024-39. PubMed ID: 11117532
[TBL] [Abstract][Full Text] [Related]
6. Coactivators PGC-1beta and SRC-1 interact functionally to promote the agonist activity of the selective estrogen receptor modulator tamoxifen.
Kressler D; Hock MB; Kralli A
J Biol Chem; 2007 Sep; 282(37):26897-26907. PubMed ID: 17631495
[TBL] [Abstract][Full Text] [Related]
7. A homogeneous in vitro functional assay for estrogen receptors: coactivator recruitment.
Liu J; Knappenberger KS; Kack H; Andersson G; Nilsson E; Dartsch C; Scott CW
Mol Endocrinol; 2003 Mar; 17(3):346-55. PubMed ID: 12554768
[TBL] [Abstract][Full Text] [Related]
8. Synergism between ERalpha transactivation function 1 (AF-1) and AF-2 mediated by steroid receptor coactivator protein-1: requirement for the AF-1 alpha-helical core and for a direct interaction between the N- and C-terminal domains.
Métivier R; Penot G; Flouriot G; Pakdel F
Mol Endocrinol; 2001 Nov; 15(11):1953-70. PubMed ID: 11682626
[TBL] [Abstract][Full Text] [Related]
9. Coactivator peptides have a differential stabilizing effect on the binding of estrogens and antiestrogens with the estrogen receptor.
Gee AC; Carlson KE; Martini PG; Katzenellenbogen BS; Katzenellenbogen JA
Mol Endocrinol; 1999 Nov; 13(11):1912-23. PubMed ID: 10551784
[TBL] [Abstract][Full Text] [Related]
10. Ligand-selective interactions of ER detected in living cells by fluorescence resonance energy transfer.
Weatherman RV; Chang CY; Clegg NJ; Carroll DC; Day RN; Baxter JD; McDonnell DP; Scanlan TS; Schaufele F
Mol Endocrinol; 2002 Mar; 16(3):487-96. PubMed ID: 11875107
[TBL] [Abstract][Full Text] [Related]
11. Estrogen response element-dependent regulation of transcriptional activation of estrogen receptors alpha and beta by coactivators and corepressors.
Klinge CM; Jernigan SC; Mattingly KA; Risinger KE; Zhang J
J Mol Endocrinol; 2004 Oct; 33(2):387-410. PubMed ID: 15525597
[TBL] [Abstract][Full Text] [Related]
12. Selection of estrogen receptor beta- and thyroid hormone receptor beta-specific coactivator-mimetic peptides using recombinant peptide libraries.
Northrop JP; Nguyen D; Piplani S; Olivan SE; Kwan ST; Go NF; Hart CP; Schatz PJ
Mol Endocrinol; 2000 May; 14(5):605-22. PubMed ID: 10809226
[TBL] [Abstract][Full Text] [Related]
13. Differential recruitment of the mammalian mediator subunit TRAP220 by estrogen receptors ERalpha and ERbeta.
Wärnmark A; Almlöf T; Leers J; Gustafsson JA; Treuter E
J Biol Chem; 2001 Jun; 276(26):23397-404. PubMed ID: 11303023
[TBL] [Abstract][Full Text] [Related]
14. Full activation of estrogen receptor alpha activation function-1 induces proliferation of breast cancer cells.
Fujita T; Kobayashi Y; Wada O; Tateishi Y; Kitada L; Yamamoto Y; Takashima H; Murayama A; Yano T; Baba T; Kato S; Kawabe Y; Yanagisawa J
J Biol Chem; 2003 Jul; 278(29):26704-14. PubMed ID: 12738788
[TBL] [Abstract][Full Text] [Related]
15. Dissection of the LXXLL nuclear receptor-coactivator interaction motif using combinatorial peptide libraries: discovery of peptide antagonists of estrogen receptors alpha and beta.
Chang Cy; Norris JD; Grøn H; Paige LA; Hamilton PT; Kenan DJ; Fowlkes D; McDonnell DP
Mol Cell Biol; 1999 Dec; 19(12):8226-39. PubMed ID: 10567548
[TBL] [Abstract][Full Text] [Related]
16. Development of peptide antagonists that target estrogen receptor beta-coactivator interactions.
Hall JM; Chang CY; McDonnell DP
Mol Endocrinol; 2000 Dec; 14(12):2010-23. PubMed ID: 11117531
[TBL] [Abstract][Full Text] [Related]
17. Identification of a negative regulatory surface within estrogen receptor alpha provides evidence in support of a role for corepressors in regulating cellular responses to agonists and antagonists.
Huang HJ; Norris JD; McDonnell DP
Mol Endocrinol; 2002 Aug; 16(8):1778-92. PubMed ID: 12145334
[TBL] [Abstract][Full Text] [Related]
18. Differential SERM activation of the estrogen receptors (ERalpha and ERbeta) at AP-1 sites.
Weatherman RV; Clegg NJ; Scanlan TS
Chem Biol; 2001 May; 8(5):427-36. PubMed ID: 11358690
[TBL] [Abstract][Full Text] [Related]
19. CIA, a novel estrogen receptor coactivator with a bifunctional nuclear receptor interacting determinant.
Sauvé F; McBroom LD; Gallant J; Moraitis AN; Labrie F; Giguère V
Mol Cell Biol; 2001 Jan; 21(1):343-53. PubMed ID: 11113208
[TBL] [Abstract][Full Text] [Related]
20. Activity of a tamoxifen-raloxifene hybrid ligand for estrogen receptors at an AP-1 site.
Weatherman RV; Carroll DC; Scanlan TS
Bioorg Med Chem Lett; 2001 Dec; 11(24):3129-31. PubMed ID: 11720858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
